Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Atara Biotherapeutics (ATRA) Other Non Operating Income (2022 - 2025)

Atara Biotherapeutics' Other Non Operating Income history spans 4 years, with the latest figure at -$49000.0 for Q4 2025.

  • For Q4 2025, Other Non Operating Income rose 44.94% year-over-year to -$49000.0; the TTM value through Dec 2025 reached -$34000.0, down 106.44%, while the annual FY2025 figure was -$34000.0, 106.44% down from the prior year.
  • Other Non Operating Income reached -$49000.0 in Q4 2025 per ATRA's latest filing, down from $4000.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $555000.0 in Q3 2024 to a low of -$309000.0 in Q3 2022.
  • Average Other Non Operating Income over 4 years is -$28312.5, with a median of -$19500.0 recorded in 2023.
  • The largest YoY upside for Other Non Operating Income was 2155.56% in 2024 against a maximum downside of 641.67% in 2024.
  • A 4-year view of Other Non Operating Income shows it stood at -$69000.0 in 2022, then soared by 82.61% to -$12000.0 in 2023, then tumbled by 641.67% to -$89000.0 in 2024, then surged by 44.94% to -$49000.0 in 2025.
  • Per Business Quant, the three most recent readings for ATRA's Other Non Operating Income are -$49000.0 (Q4 2025), $4000.0 (Q3 2025), and $22000.0 (Q2 2025).